Paramount Lawyer Targeted ‘Some’ Critics as Warner Deal Heads to Court

Paramount chief legal officer Makan Delrahim did not declare every opponent of the Warner Bros. Discovery acquisition an antisemite. He attributed antisemitic motives to “some” people trying to harm the transaction, while Axios’s June 16 account also said Paramount was not alleging that the state attorneys general themselves were driven by antisemitism.

The practical focus has since shifted from that inflammatory allegation to the acquisition’s legal status. As of August 13, 2026, the transaction remains uncompleted: the Associated Press’s August 6 coverage records UK clearance for the $81 billion takeover, legally binding broadcasting protections and a continuing challenge from 12 US states, with a 12-day antitrust trial scheduled to begin in early March 2027.

The allegation was serious but limited in scope

Delrahim’s use of “some” is essential to an accurate account. His language alleged prejudice within part of the opposition; it did not establish that prejudice as the shared motive of everyone questioning the transaction. Converting that qualified allegation into a claim about “all opponents” changes both its subject and its reach.

The distinction does not make the original comment harmless or unimportant. A chief legal officer publicly connected resistance to a major corporate transaction with religious animus without identifying all the people he meant or providing a measurable basis for determining how much of the campaign was affected. That framing inevitably placed motives alongside the substantive questions about media consolidation.

It is possible for antisemitic rhetoric to appear within a politically diverse campaign while other participants raise independent competition, labor or editorial concerns. Evidence about one speaker or incident cannot automatically establish the motives of state officials, unions, performers or other critics. Equally, the existence of a formal antitrust case does not prove that every statement made under the broader anti-merger banner is free of prejudice.

The most defensible reading is therefore narrow: Delrahim made an allegation about an unspecified portion of the opposition. Paramount’s position, as publicly described, did not turn that allegation into a blanket accusation against every critic or the attorneys general pursuing the transaction in court.

Federal clearance did not end the US dispute

The federal government reached a competition conclusion favorable to Paramount. In its June 12 closing statement, the US Justice Department said an eight-month investigation involving more than two million documents found the transaction unlikely to harm competition or consumers in subscription streaming, linear television, or theatrical film development, production and distribution.

That decision addressed the Justice Department’s antitrust mandate. It was not a ruling on whether Delrahim had accurately characterized any merger opponents, nor did it prevent state authorities from advancing their own case. Federal clearance and state litigation can coexist because they are decisions by different actors at different procedural stages.

The Justice Department’s reasoning also shows why the public argument cannot be reduced to a contest over political motives. Its assessment concerned competitive alternatives in streaming, content licensing, linear television and theatrical output. Those questions are evaluated through market definitions, commercial incentives and evidence about likely effects—not by determining whether criticism of the Ellison family or Paramount is politically sympathetic.

The states’ challenge likewise presents a legal claim rather than a referendum on the character of the entire opposition. The coalition contends that combining the companies would diminish competition and reduce choices for moviegoers and cable customers. Paramount disputes that theory, leaving a court to assess the parties’ evidence.

UK approval came with boundaries

British clearance removed an overseas obstacle, but it was not unconditional in every policy dimension. Paramount accepted protections intended to preserve a range of broadcasting and on-demand services, including separate editorial direction for Channel 5 from CBS and CNN and distinctions between certain linear, on-demand and children’s services.

Those commitments illustrate a separate category of concern. An antitrust authority may decide that a transaction does not substantially lessen competition while a government still seeks safeguards for broadcasting plurality or editorial independence. Neither conclusion answers whether particular campaigners acted from antisemitism.

The UK decision also cannot resolve litigation in the United States. Regulatory approval is jurisdiction-specific: it shows that one authority did not find sufficient grounds to block a transaction under its mandate and the commitments before it. It does not compel another authority or court applying different law to reach the same result.

Why “the opposition” is too broad a label

Opposition to a media acquisition can encompass actors with different legal standing, evidence and objectives. State attorneys general can pursue statutory competition claims; labor organizations may focus on employment and bargaining power; creative professionals may emphasize production opportunities; and media observers may scrutinize control of news operations. Treating those positions as one coordinated ideology makes the conflict easier to describe but less accurate.

The same separation is necessary when evaluating antisemitism. A credible allegation should be tied to identifiable language, conduct or participants. It should not be inferred solely from opposition to a transaction involving Jewish executives, just as a formal antitrust objection should not be treated as proof that prejudice is absent everywhere else in the campaign.

This is more than a semantic correction. A blanket description can delegitimize evidence-based scrutiny, while dismissing the possibility of antisemitism without examining particular conduct can obscure genuine prejudice. Keeping the claims distinct preserves a standard by which each can be assessed on its own evidence.

What has changed since the June controversy

The accusation has not become the legal test for the acquisition. Paramount has obtained consequential regulatory decisions in its favor, including federal and UK clearance, but the transaction remains pending because the multistate challenge has moved toward trial.

The verified record supports neither “everyone approved the deal” nor “Paramount called every opponent an antisemite.” Delrahim referred to “some” critics; regulators have reached different procedural positions; and a US court has yet to resolve the states’ challenge.

The acquisition’s next decisive stage is therefore evidentiary rather than rhetorical. The court will consider competition claims against the transaction, while Delrahim’s allegation remains a disputed characterization of part of the political campaign surrounding it. Conflating those two disputes would exaggerate the company’s accusation and obscure the legal issue that now determines whether the deal can proceed.

Also read:

• Paramount Skydance Flexes Financial Muscle in Q1 2026: Revenue Hits $7.3B, Up 2% — Proof It Can Close the Warner Bros. Discovery Deal
• From Hollywood Merger to Geopolitical Thriller: How Foreign Cash Is Turning the Paramount-Warner Bros. Deal Into a National Security Saga
• Lawyer Submits Anti-AI Document That Appears to Have Been Created Using AI